Sector & Market
Avalo Therapeutics Jumps 60% on Trial Success
Avalo Therapeutics shares surged ~60% after reporting successful Phase 2 trial results for its hidradenitis suppurativa drug today.
Super Micro Computer rose ~17% despite missing revenue targets, beat
